Literature DB >> 7884911

Delineating minimal protein domains and promoter elements for transcriptional activation by lentivirus Tat proteins.

C D Southgate1, M R Green.   

Abstract

Lentivirus Tat proteins comprise a novel class of RNA-binding transcriptional activators that are essential for viral replication. In this study, we performed a series of protein fusion experiments to delineate the minimal protein domains and promoter elements required for Tat action. We show that a 15-amino-acid region of equine infectious anemia virus (EIAV) Tat protein, when fused to the GAL4 or LexA DNA binding domain, can activate transcription in appropriate promoter contexts. In the natural human immunodeficiency virus type 1 long terminal repeat, activation by Tat is dependent on multiple binding sites for the cellular transcription factor SP1. We delineate a 114-amino-acid region of the SP1 glutamine-rich activation domain that when fused to the GAL4 DNA binding domain can support transcription activation by Tat. Using these Tat and SP1 derivatives, we show that Tat activation can be reconstructed on a completely synthetic promoter lacking all cis-acting elements unique to the human immunodeficiency virus long terminal repeat. Our results indicate that lentivirus Tat proteins have essential properties of typical cellular transcriptional activators and define useful reagents for studying the detailed mechanism of Tat action.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884911      PMCID: PMC188939     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.

Authors:  L S Tiley; S J Madore; M H Malim; B R Cullen
Journal:  Genes Dev       Date:  1992-11       Impact factor: 11.361

2.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

3.  HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.

Authors:  M F Laspia; A P Rice; M B Mathews
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 4.  How eukaryotic transcriptional activators work.

Authors:  M Ptashne
Journal:  Nature       Date:  1988-10-20       Impact factor: 49.962

5.  Anti-termination of transcription within the long terminal repeat of HIV-1 by tat gene product.

Authors:  S Y Kao; A F Calman; P A Luciw; B M Peterlin
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

6.  Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain.

Authors:  J T Kadonaga; K R Carner; F R Masiarz; R Tjian
Journal:  Cell       Date:  1987-12-24       Impact factor: 41.582

7.  Activation of the AIDS retrovirus promoter by the cellular transcription factor, Sp1.

Authors:  K A Jones; J T Kadonaga; P A Luciw; R Tjian
Journal:  Science       Date:  1986-05-09       Impact factor: 47.728

8.  Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.

Authors:  P Dorn; L DaSilva; L Martarano; D Derse
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

9.  Multiple functional domains of Tat, the trans-activator of HIV-1, defined by mutational analysis.

Authors:  M Kuppuswamy; T Subramanian; A Srinivasan; G Chinnadurai
Journal:  Nucleic Acids Res       Date:  1989-05-11       Impact factor: 16.971

10.  Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells.

Authors:  C E Hart; C Y Ou; J C Galphin; J Moore; L T Bacheler; J J Wasmuth; S R Petteway; G Schochetman
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

View more
  10 in total

1.  Sequential steps in Tat trans-activation of HIV-1 mediated through cellular DNA, RNA, and protein binding factors.

Authors:  A Gatignol; M Duarte; L Daviet; Y N Chang; K T Jeang
Journal:  Gene Expr       Date:  1996

2.  Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.

Authors:  C Neuveut; K T Jeang
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Physical and functional interactions between herpes simplex virus immediate-early proteins ICP4 and ICP27.

Authors:  C A Panagiotidis; E K Lium; S J Silverstein
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

4.  NMR analysis of the trans-activation response (TAR) RNA element of equine infectious anemia virus.

Authors:  D W Hoffman; S W White
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

5.  RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat.

Authors:  P S Pendergrast; N Hernandez
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

6.  Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat.

Authors:  R F Chun; O J Semmes; C Neuveut; K T Jeang
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex.

Authors:  Yick-Pang Ching; Abel C S Chun; King-Tung Chin; Zhi-Qing Zhang; Kuan-Teh Jeang; Dong-Yan Jin
Journal:  Retrovirology       Date:  2004-07-30       Impact factor: 4.602

8.  HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs.

Authors:  Tamal Raha; S W Grace Cheng; Michael R Green
Journal:  PLoS Biol       Date:  2005-02-08       Impact factor: 8.029

9.  Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription.

Authors:  Manuela Vanti; Edurne Gallastegui; Iñaki Respaldiza; Alfonso Rodríguez-Gil; Fernando Gómez-Herreros; Silvia Jimeno-González; Albert Jordan; Sebastián Chávez
Journal:  PLoS Genet       Date:  2009-01-16       Impact factor: 5.917

Review 10.  Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders.

Authors:  Vincenzo Cavalieri; Elena Baiamonte; Melania Lo Iacono
Journal:  Viruses       Date:  2018-06-09       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.